WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 475

Legislative bill overview

SB 475 would prohibit the use of aluminum compounds as ingredients in vaccines administered in Montana. The bill died in the legislative process after being tabled in committee and missing the deadline for general bill transmittal during the 2025 Montana legislative session.

Why is this important

Vaccines contain trace amounts of aluminum salts, which are used as adjuvants to strengthen immune response. This bill represents ongoing public debate about vaccine ingredients and regulatory approaches to pharmaceutical manufacturing, though the scientific evidence regarding aluminum in vaccines remains a point of disagreement between public health authorities and some advocacy groups.

Potential points of contention

  • Scientific evidence dispute: Major health organizations (CDC, WHO, FDA) conclude aluminum levels in vaccines are safe, while proponents argue precautionary approaches are warranted despite limited evidence of harm at current exposure levels
  • Regulatory authority and uniformity: A state-level ban could conflict with federal FDA approval processes and create implementation challenges for vaccine manufacturers and healthcare providers
  • Access and public health impact: Restricting approved vaccines could reduce vaccination rates, potentially affecting disease prevention efforts, though supporters argue alternative adjuvant formulations exist

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.